播種性血管内凝固症候群（DIC）の世界市場レポート 2025年

播種性血管内凝固症候群（DIC）市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.0％で5億9,000万米ドルに成長します。予測期間中の成長は、標的治療の採用の増加、疾患の早期発見への注目の高まり、ヘルスケアインフラへの投資の増加、凝固異常症治療に関する臨床研究の拡大、希少血液疾患に対する認識の高まりなどに起因すると考えられます。主な動向としては、診断アッセイの発展、新規抗凝固療法の採用、個別化医療アプローチの台頭、診断におけるAIの統合、患者モニタリング技術の向上、標的治療の開発などが挙げられます。

がんの罹患率の上昇が播種性血管内凝固症候群（DIC）市場の成長を牽引すると予想されます。がんは、正常組織に侵入して損傷を与える異常細胞の無秩序な増殖と拡散を特徴とする疾患です。がん患者の増加は、高齢化、ライフスタイルの変化、環境暴露、感染症、遺伝的素因などの要因に起因しています。がんは、腫瘍が産生する凝固促進物質によって凝固カスケードを過剰に活性化させ、広範な血液凝固や出血をもたらすことによって、播種性血管内凝固症候群（DIC）を引き起こす可能性があります。例えば、2024年5月、米国の政府機関である国立がん研究所は、2022年に世界で約2,000万人の新規がん患者と970万人のがん関連死が記録されたと報告しました。予測によれば、この数字は2040年までに年間2,990万人の新規罹患者と1,530万人の死亡者に増加する可能性があります。その結果、がん有病率の増加が播種性血管内凝固症候群（DIC）市場の成長を促進しています。

播種性血管内凝固症候群（DIC）市場の主要企業は、次世代血液凝固検査などの凝固診断技術を進歩させ、診断精度、スピード、利便性を向上させています。これらの技術革新はタイムリーな介入を可能にし、患者の転帰を向上させる。次世代血液凝固検査は、従来の方法よりも正確かつ効率的、包括的に血液凝固を評価するように設計された高度な診断ツールです。例えば、2022年6月、英国のヘルスケア企業であるルミラデックス・リミテッドは、NT-proBNP検査と更新D-ダイマー検査のCEマーク承認を取得し、心血管検査ポートフォリオを拡充しました。これらの機能強化により、ルミラデックス・プラットフォームは、心不全の診断や静脈血栓塞栓症の除外をポイントオブケアで行う臨床医を支援する能力を強化しました。このような進歩は、播種性血管内凝固症候群（DIC）を含む心血管および血栓性疾患の早期発見と管理を改善することを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界播種性血管内凝固症候群（DIC） PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の播種性血管内凝固症候群（DIC）市場：成長率分析
• 世界の播種性血管内凝固症候群（DIC）市場の実績：規模と成長, 2019-2024
• 世界の播種性血管内凝固症候群（DIC）市場の予測：規模と成長, 2024-2029, 2034F
• 世界播種性血管内凝固症候群（DIC）総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の播種性血管内凝固症候群（DIC）市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬
• 輸血
• 手術
• その他の治療法
• 世界の播種性血管内凝固症候群（DIC）市場診断別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液塗抹標本検査を含む全血球算定
• 部分トロンボプラスチン時間（PTT）
• フィブリノーゲン血液検査
• Dダイマー
• その他の診断
• 世界の播種性血管内凝固症候群（DIC）市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 非経口
• その他の投与経路
• 世界の播種性血管内凝固症候群（DIC）市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の播種性血管内凝固症候群（DIC）市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• ホームケア
• その他のエンドユーザー
• 世界の播種性血管内凝固症候群（DIC）市場医薬品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗凝固薬
• 抗血小板薬
• 線溶薬
• 凝血促進剤
• 抗トロンビン療法
• 世界の播種性血管内凝固症候群（DIC）市場輸血の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血小板輸血
• 新鮮凍結血漿（FFP）
• クリオプレシピテート輸血
• 赤血球輸血
• 世界の播種性血管内凝固症候群（DIC）市場、手術の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血栓の外科的除去
• 臓器手術
• 世界の播種性血管内凝固症候群（DIC）市場、その他の治療法のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血漿交換
• 支持療法
• ステロイド療法

第7章 地域別・国別分析

• 世界の播種性血管内凝固症候群（DIC）市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の播種性血管内凝固症候群（DIC）市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 播種性血管内凝固症候群（DIC）市場：競合情勢
• 播種性血管内凝固症候群（DIC）市場：企業プロファイル
  • Nihon Kohden Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Merck & Co.Inc.
• Bayer AG
• Sanofi S.A.
• AstraZeneca plc
• Abbott Laboratories
• Novartis AG
• Thermo Fisher Scientific Inc.
• Fresenius Kabi AG
• GlaxoSmithKline plc
• Danaher Corporation
• Eli Lily and Company
• Siemens Healthineers
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Grifols S.A.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 播種性血管内凝固症候群（DIC）市場2029：新たな機会を提供する国
• 播種性血管内凝固症候群（DIC）市場2029：新たな機会を提供するセグメント
• 播種性血管内凝固症候群（DIC）市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Disseminated intravascular coagulation (DIC) is a severe, life-threatening condition marked by excessive blood clotting, which eventually leads to significant bleeding due to the depletion of clotting factors and platelets. It is triggered by underlying conditions such as sepsis, trauma, malignancies, and obstetric complications.

The primary treatments for disseminated intravascular coagulation (DIC) include medications, transfusions, surgery, and other therapeutic approaches. Medications consist of anticoagulants, blood products, and supportive drugs aimed at managing clotting and bleeding complications related to DIC. Diagnostic methods include a complete blood count with blood smear examination, partial thromboplastin time (PTT), fibrinogen blood test, D-dimer test, and other diagnostic procedures. These tests are administered through various routes, such as oral, parenteral, and alternative methods, and are distributed through hospital pharmacies, retail pharmacies, and online pharmacies. Treatment options are utilized across hospitals, specialty clinics, homecare settings, and other healthcare facilities.

The disseminated intravascular coagulation (DIC) market research report is one of a series of new reports from The Business Research Company that provides disseminated intravascular coagulation (DIC) market statistics, including the disseminated intravascular coagulation (DIC) industry's global market size, regional shares, competitors with a disseminated intravascular coagulation (DIC) market share, detailed disseminated intravascular coagulation (DIC) market segments, market trends and opportunities, and any further data you may need to thrive in the disseminated intravascular coagulation (DIC) industry. This disseminated intravascular coagulation (DIC) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The disseminated intravascular coagulation (DIC) market size has grown strongly in recent years. It will grow from $0.46 billion in 2024 to $0.49 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth during the historic period can be attributed to the increasing prevalence of sepsis, a rise in trauma cases, a growing incidence of cancer, higher healthcare expenditures, improved awareness among healthcare professionals, and the increased adoption of targeted therapies.

The disseminated intravascular coagulation (DIC) market size is expected to see strong growth in the next few years. It will grow to $0.59 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth during the forecast period can be attributed to the rising adoption of targeted therapies, increased focus on early disease detection, growing investments in healthcare infrastructure, expansion of clinical research on coagulopathy treatments, and greater awareness of rare hematological conditions. Key trends include advancements in diagnostic assays, adoption of novel anticoagulant therapies, the rise of personalized medicine approaches, integration of AI in diagnostics, improved patient monitoring technologies, and the development of targeted treatments.

The rising incidence of cancer is expected to drive the growth of the disseminated intravascular coagulation (DIC) market. Cancer is a disease characterized by the uncontrolled proliferation and spread of abnormal cells, which can invade and damage normal tissues. The increasing number of cancer cases is attributed to factors such as an aging population, lifestyle changes, environmental exposure, infections, and genetic predisposition. Cancer can lead to disseminated intravascular coagulation (DIC) by excessively activating the coagulation cascade through tumor-produced procoagulant substances, resulting in widespread clotting and bleeding. For example, in May 2024, the National Cancer Institute, a US-based government agency, reported that in 2022, approximately 20 million new cancer cases and 9.7 million cancer-related deaths were recorded globally. Projections indicate that these figures could rise to 29.9 million new cases and 15.3 million deaths annually by 2040. As a result, the increasing prevalence of cancer is fueling the growth of the disseminated intravascular coagulation (DIC) market.

Leading companies in the disseminated intravascular coagulation (DIC) market are advancing coagulation diagnostic technologies, such as next-generation blood clotting tests, to improve diagnostic accuracy, speed, and convenience. These innovations enable timely intervention and enhance patient outcomes. Next-generation blood clotting tests are advanced diagnostic tools designed to assess blood coagulation more precisely, efficiently, and comprehensively than traditional methods. For instance, in June 2022, LumiraDx Limited, a UK-based healthcare company, expanded its cardiovascular testing portfolio by obtaining CE Mark approvals for its NT-proBNP and updated D-Dimer tests. These enhancements strengthen the LumiraDx Platform's ability to assist clinicians in diagnosing heart failure and ruling out venous thromboembolism at the point of care. Such advancements aim to improve the early detection and management of cardiovascular and thrombotic conditions, including disseminated intravascular coagulation (DIC).

In March 2024, MediLink Therapeutics (Suzhou) Co. Ltd., a China-based biotech company, entered into a collaboration with Amgen Inc. to evaluate YL201 for the treatment of thrombotic disorders, including disseminated intravascular coagulation (DIC). This partnership seeks to advance blood clotting therapies, improving treatment effectiveness and patient outcomes. Amgen Inc. is a US-based biopharmaceutical company specializing in the discovery, development, and manufacturing of innovative therapeutics.

Major players in the disseminated intravascular coagulation (DIC) market are Nihon Kohden Corporation, Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., AbbVie Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, Thermo Fisher Scientific Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Danaher Corporation, Eli Lily and Company, Siemens Healthineers, Teva Pharmaceutical Industries Ltd., Mylan N.V., Grifols S.A., Eisai Co. Ltd., Beckman Coulter Inc., Sysmex Corporation, and Bio-Rad Laboratories Inc.

North America was the largest region in the disseminated intravascular coagulation (DIC) market in 2024. The regions covered in disseminated intravascular coagulation (DIC) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the disseminated intravascular coagulation (DIC) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The disseminated intravascular coagulation (DIC) market consists of revenues earned by entities by providing services such as pharmaceutical treatments, anticoagulant therapies, diagnostic services, and critical care interventions. The market value includes the value of related goods sold by the service provider or included within the service offering. The disseminated intravascular coagulation (DIC) market also includes sales of diagnostic tools, anticoagulant medications, and blood products such as platelets, fresh frozen plasma, or cryoprecipitate. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Disseminated Intravascular Coagulation (DIC) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on disseminated intravascular coagulation (dic) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for disseminated intravascular coagulation (dic) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The disseminated intravascular coagulation (dic) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Medicines; Transfusions; Surgery; Other Treatments
• 2) By Diagnosis: Complete Blood Count With Blood Smear Exam; Partial Thromboplastin Time (PTT); Fibrinogen Blood Test; D-dimer; Other Diagnoses
• 3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
• 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
• 5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
• Subsegments:
• 1) By Medicines: Anticoagulants; Antiplatelet Drugs; Fibrinolytics; Procoagulants; Antithrombin Therapy
• 2) By Transfusions: Platelet Transfusion; Fresh Frozen Plasma (FFP); Cryoprecipitate Transfusion; Red Blood Cell Transfusion
• 3) By Surgery: Surgical Removal Of Thrombus; Organ Surgery
• 4) By Other Treatments: Plasma Exchange; Supportive Care; Steroid Therapy
• Companies Mentioned: Nihon Kohden Corporation; Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Disseminated Intravascular Coagulation (DIC) Market Characteristics

3. Disseminated Intravascular Coagulation (DIC) Market Trends And Strategies

4. Disseminated Intravascular Coagulation (DIC) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Disseminated Intravascular Coagulation (DIC) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Disseminated Intravascular Coagulation (DIC) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Disseminated Intravascular Coagulation (DIC) Market Growth Rate Analysis
• 5.4. Global Disseminated Intravascular Coagulation (DIC) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Disseminated Intravascular Coagulation (DIC) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Disseminated Intravascular Coagulation (DIC) Total Addressable Market (TAM)

6. Disseminated Intravascular Coagulation (DIC) Market Segmentation

• 6.1. Global Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medicines
• Transfusions
• Surgery
• Other Treatments
• 6.2. Global Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Complete Blood Count with Blood Smear Exam
• Partial Thromboplastin Time (PTT)
• Fibrinogen Blood Test
• D-dimer
• Other Diagnoses
• 6.3. Global Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Other Routes Of Administration
• 6.4. Global Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• 6.5. Global Disseminated Intravascular Coagulation (DIC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Homecare
• Other End-Users
• 6.6. Global Disseminated Intravascular Coagulation (DIC) Market, Sub-Segmentation Of Medicines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anticoagulants
• Antiplatelet Drugs
• Fibrinolytics
• Procoagulants
• Antithrombin Therapy
• 6.7. Global Disseminated Intravascular Coagulation (DIC) Market, Sub-Segmentation Of Transfusions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Platelet Transfusion
• Fresh Frozen Plasma (FFP)
• Cryoprecipitate Transfusion
• Red Blood Cell Transfusion
• 6.8. Global Disseminated Intravascular Coagulation (DIC) Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgical Removal Of Thrombus
• Organ Surgery
• 6.9. Global Disseminated Intravascular Coagulation (DIC) Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plasma Exchange
• Supportive Care
• Steroid Therapy

7. Disseminated Intravascular Coagulation (DIC) Market Regional And Country Analysis

• 7.1. Global Disseminated Intravascular Coagulation (DIC) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Disseminated Intravascular Coagulation (DIC) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Disseminated Intravascular Coagulation (DIC) Market

• 8.1. Asia-Pacific Disseminated Intravascular Coagulation (DIC) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Disseminated Intravascular Coagulation (DIC) Market

• 9.1. China Disseminated Intravascular Coagulation (DIC) Market Overview
• 9.2. China Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Disseminated Intravascular Coagulation (DIC) Market

• 10.1. India Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Disseminated Intravascular Coagulation (DIC) Market

• 11.1. Japan Disseminated Intravascular Coagulation (DIC) Market Overview
• 11.2. Japan Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Disseminated Intravascular Coagulation (DIC) Market

• 12.1. Australia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Disseminated Intravascular Coagulation (DIC) Market

• 13.1. Indonesia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Disseminated Intravascular Coagulation (DIC) Market

• 14.1. South Korea Disseminated Intravascular Coagulation (DIC) Market Overview
• 14.2. South Korea Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Disseminated Intravascular Coagulation (DIC) Market

• 15.1. Western Europe Disseminated Intravascular Coagulation (DIC) Market Overview
• 15.2. Western Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Disseminated Intravascular Coagulation (DIC) Market

• 16.1. UK Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Disseminated Intravascular Coagulation (DIC) Market

• 17.1. Germany Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Disseminated Intravascular Coagulation (DIC) Market

• 18.1. France Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Disseminated Intravascular Coagulation (DIC) Market

• 19.1. Italy Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Disseminated Intravascular Coagulation (DIC) Market

• 20.1. Spain Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Disseminated Intravascular Coagulation (DIC) Market

• 21.1. Eastern Europe Disseminated Intravascular Coagulation (DIC) Market Overview
• 21.2. Eastern Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Disseminated Intravascular Coagulation (DIC) Market

• 22.1. Russia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Disseminated Intravascular Coagulation (DIC) Market

• 23.1. North America Disseminated Intravascular Coagulation (DIC) Market Overview
• 23.2. North America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Disseminated Intravascular Coagulation (DIC) Market

• 24.1. USA Disseminated Intravascular Coagulation (DIC) Market Overview
• 24.2. USA Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Disseminated Intravascular Coagulation (DIC) Market

• 25.1. Canada Disseminated Intravascular Coagulation (DIC) Market Overview
• 25.2. Canada Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Disseminated Intravascular Coagulation (DIC) Market

• 26.1. South America Disseminated Intravascular Coagulation (DIC) Market Overview
• 26.2. South America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Disseminated Intravascular Coagulation (DIC) Market

• 27.1. Brazil Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Disseminated Intravascular Coagulation (DIC) Market

• 28.1. Middle East Disseminated Intravascular Coagulation (DIC) Market Overview
• 28.2. Middle East Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Disseminated Intravascular Coagulation (DIC) Market

• 29.1. Africa Disseminated Intravascular Coagulation (DIC) Market Overview
• 29.2. Africa Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Disseminated Intravascular Coagulation (DIC) Market Competitive Landscape And Company Profiles

• 30.1. Disseminated Intravascular Coagulation (DIC) Market Competitive Landscape
• 30.2. Disseminated Intravascular Coagulation (DIC) Market Company Profiles
  • 30.2.1. Nihon Kohden Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Disseminated Intravascular Coagulation (DIC) Market Other Major And Innovative Companies

• 31.1. Merck & Co.Inc.
• 31.2. Bayer AG
• 31.3. Sanofi S.A.
• 31.4. AstraZeneca plc
• 31.5. Abbott Laboratories
• 31.6. Novartis AG
• 31.7. Thermo Fisher Scientific Inc.
• 31.8. Fresenius Kabi AG
• 31.9. GlaxoSmithKline plc
• 31.10. Danaher Corporation
• 31.11. Eli Lily and Company
• 31.12. Siemens Healthineers
• 31.13. Teva Pharmaceutical Industries Ltd.
• 31.14. Mylan N.V.
• 31.15. Grifols S.A.

32. Global Disseminated Intravascular Coagulation (DIC) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Disseminated Intravascular Coagulation (DIC) Market

34. Recent Developments In The Disseminated Intravascular Coagulation (DIC) Market

35. Disseminated Intravascular Coagulation (DIC) Market High Potential Countries, Segments and Strategies

• 35.1 Disseminated Intravascular Coagulation (DIC) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Disseminated Intravascular Coagulation (DIC) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Disseminated Intravascular Coagulation (DIC) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer